Usual Care for Covid19

Phase-Based Progress Estimates
Ottawa Hospital Research Institute, Ottawa, Canada
Covid19+1 More
Usual Care - Other
All Sexes
Eligible conditions

Study Summary

Enhancing COVID Rehabilitation With Technology

See full description

Eligible Conditions

  • Covid19

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Compared to trials

Study Objectives

This trial is evaluating whether Usual Care will improve 1 primary outcome and 16 secondary outcomes in patients with Covid19. Measurement will happen over the course of Baseline and Week 12.

Baseline and Week 12
Change in WHODAS 2.0 score
Digit Span subset
Hopkins Verbal Learning Test-Revised (HVLT-R)
Oral Trail Making Test A and B
Phonemic and Semantic Verbal Fluency (or Controlled Oral Word Association Test)
Trail Making Test A and B
Week 12
Fatigue Numeric Rating Scale
Fatigue Severity Scale
MRC Dyspnoea Scale
Pain Numeric Rating Scale
Week 12

Trial Safety

Safety Estimate

1 of 3

Compared to trials

Trial Design

2 Treatment Groups

Usual Care
1 of 2
Electronic Case Management plus Usual Care
1 of 2
Active Control
Experimental Treatment

This trial requires 152 total participants across 2 different treatment groups

This trial involves 2 different treatments. Usual Care is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Electronic Case Management plus Usual CareParticipants randomized to the experimental arm will receive assessment, investigation and management as the Active Comparator Arm plus access to an electronic case management platform - NexJ Connected Wellness ( which complements the rehabilitation plan. This would include for example setting targets for activity that would be monitored with NexJ; educational materials; and support with medication adherence by reminders. The NexJ platform will include the following sections: Trusted Educational Content (Health Library); Symptom Tracking, Goal Setting, Community Forums and Reporting.
Usual Care
Assessment. Participants randomized to the control arm will be offered assessment by a clinician, guided by the WHO Post COVID-19 case report form. This is a clinical tool developed by WHO to guide and document the sequelae of COVID-19 and to ensure that clinical and rehabilitation needs are identified. Investigation. Clinician judgement will be used to decide on further testing needed for clinical care. Management. Control participants will receive a rehabilitation plan developed with their health professional that will be implemented in the eight weeks after their initial consultation (baseline visit). The implementation will involve face to face or virtual care from a registered health professional provided by the clinic or research staff. This may be a combination of, but not limited to, occupational therapy, physical therapy and/or social work/counselling. The frequency of treatment visits will depend on the individual treatment plan after assessment.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: module 1 will be administered at baseline only. modules 2 and 3 will be administered at baseline and 12 weeks.
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly module 1 will be administered at baseline only. modules 2 and 3 will be administered at baseline and 12 weeks. for reporting.

Who is running the study

Principal Investigator
D. S. H.
Dr. Simon Hatcher, MD
University of Ottawa

Closest Location

Ottawa Hospital Research Institute - Ottawa, Canada

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 8 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
You have a confirmed diagnosis of COVID-19 with a PCR test at least 12 weeks prior OR a confirmed Rapid Antigen Test at least 12-weeks prior OR meet Ottawa Public Health guidance for a suspected COVID-19 case. show original
You have a minimum WHODAS (36 item) sum score of 15 or more. show original
Have at least one ongoing symptom consistent with Long COVID as measured by the WHO Post COVID Case Report Form (CRF)
Be willing to use email for study activities
Be able to read and understand English or French.
Be willing and able to provide informed consent.
You are able and willing to use a smart phone application for the duration of the trial. show original
You are at least 18 years old. show original

Patient Q&A Section

Can covid19 be cured?

"Given the severity of the illness following symptomatic exposure to COVID-19, the lack of a cure may be a good thing. Symptom control has the potential to minimize the disease with increased social and economic costs." - Anonymous Online Contributor

Unverified Answer

What are common treatments for covid19?

"Patients with a recent acute respiratory illness are encouraged to stay at home unless symptomatically required. Any symptomatic patient should be evaluated with a low-risk score, and only if required should a rapid test or test with a low error rate be requested. Patients with positive symptom-based risk factors (e.g. >2 days cough, fever, shortness of breath) should also be referred for testing. In line with National Health Service priorities, the Government's interim guidelines urge us to continue to use low-risk scores in general practice, but if patient-relevant questions cannot be answered from a recent history and examination (e.g. recent exposure to visitors, work, travel), consider alternative tests such as blood tests (e.g." - Anonymous Online Contributor

Unverified Answer

What causes covid19?

"The epidemic of 2019-2019nCoV is an unprecedented event for Hong Kong, mainland China, and the world. However, the causes of the outbreak are not yet known. This article discusses the factors that could impact the transmission of2019nCoV in Hong Kong based on the public health literature. We will review the most probable factors that can affect the transmission of2019nCoV. The review will be based on the theories of microbiology, epidemiology, virology, immunology and information technology." - Anonymous Online Contributor

Unverified Answer

How many people get covid19 a year in the United States?

"There was a substantial increase in the number of hospitalized cases during the first three months of the 2019–20 coronavirus outbreak. As of September 19, this number was the highest in the United States since January 1, 2020. To monitor the dissemination of the disease, we will need to consider additional factors." - Anonymous Online Contributor

Unverified Answer

What is covid19?

"In India, the virus is prevalent among the general population, albeit less frequently in the higher strata. This pattern may be an important marker when assessing the impact of public health efforts." - Anonymous Online Contributor

Unverified Answer

What are the signs of covid19?

"There are no general case-based signs of covid19. Individuals with a history of wheeze, cough or other serious respiratory illness suggestive of other causes of respiratory illness are unlikely to have an underlying covid-related disease. A history of fevers (over38°C) and/or recent contact with people with respiratory symptoms are suggestive of a diagnosis of covid-19 and warrants further screening." - Anonymous Online Contributor

Unverified Answer

How does nexj connected wellness work?

"As part of the response to the crisis, Nexj Connected Health will be providing physical assessments, free medication refills, vaccinations, screenings, and health literacy training for vulnerable populations. Residents of the Community Clinic will be partnering with local community providers, offering free physical exams and vaccinations. In addition, Nexj will be coordinating community-wide mental health screenings at community facilities.\n\nKiller's Disease\n\nPossible long-term effects include cancer. One study estimated that the risk of cancer in patients has doubled in the past 50 years, from 2.4% to 5.7%." - Anonymous Online Contributor

Unverified Answer

What are the latest developments in nexj connected wellness for therapeutic use?

"This article is a review of recent, advances in NxJC treatment. The use of NxJC for treatment options to help patients with different ailments is a growing field for researchers. There is much research being done with multiple ailments pertaining to the use of NxJC. This database provides the latest updates of the best treatments available, and should be useful to practitioners." - Anonymous Online Contributor

Unverified Answer

Does nexj connected wellness improve quality of life for those with covid19?

"The study reveals that an unenhanced CWH program is a promising intervention to promote wellness and health-related quality-of-life improvement for patients with COVID-19. The implementation of an integrated program may become a recommended approach in the future." - Anonymous Online Contributor

Unverified Answer

How serious can covid19 be?

"A severe form of coronavirus pneumonia, caused by SARS-CoV-2, is an extremely rare medical condition and a life-threatening condition requiring treatment with oxygen and intensive care. The serious and life-threatening nature of the disease has significant implications for health care planners and providers." - Anonymous Online Contributor

Unverified Answer

What is the average age someone gets covid19?

"The average age of someone who has contracted the virus is 68.1 (standard deviation 17.6); age of infection can be found online.. If you are new to the disease, please consult a professional healthcare provider that can also help guide treatment plans to help slow or halt the spread of the virus." - Anonymous Online Contributor

Unverified Answer

What is nexj connected wellness?

"The answer: the answer: Our program has helped to increase nexi and answer: we believe our program can help other wellness companies in other country to promote the connected wellness." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Covid19 by sharing your contact details with the study coordinator.